DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

Raymond James Initiates Coverage On Tandem Diabetes Care with Outperform Rating, Announces $85 Price Target

Raymond James analyst Jayson Bedford initiates coverage on Tandem Diabetes Care (NASDAQ:TNDM) with a Outperform rating and a $85 price target.

Benzinga · 02/06/2020 10:05

Raymond James analyst Jayson Bedford initiates coverage on Tandem Diabetes Care (NASDAQ:TNDM) with a Outperform rating and a $85 price target.